Differences in Coagulation and Haemostatic Parameters in Normal Women of Childbearing Age from Different Ethnic Groups and Geographical Locations

Summary

A comparative study of coagulation and fibrinolytic laboratory parameters was undertaken in four countries (Salvador, Brazil; Singapore; Santiago, Chile and Dublin, Ireland) among apparently healthy women of reproductive age. A continuous external quality control scheme of the laboratory measurements was employed to permit comparison among centres. Significant and consistent differences were found between the four centres. In Dublin, the prothrombin time and activated partial thromboplastin time (APTT) were accelerated, and the specific factor assays showed more activity, whereas the antiprotease levels were higher than in the other centres. In Salvador, a contrasting tendency was found with longer prothrombin times and APTT and lower Factor VII and antiprotease levels. The results from the other two centres were approximately midway between these two extremes. The study has revealed important differences in the coagulation and haemostatic tests between women from widely diverse geographical areas. It is not certain whether these are due to ethnic, nutritional or economic factors but they may be related to the apparent varying incidence of thrombosis in these ethnic groups.

Keywords

Ethnic differences - Blood coagulation - Collaborative study Summary

• References

• 1 Clauss A. Gerinnungsphysiologische Schnellmethode zur Bestimmung des Fibrinogens. Acta Haematol 1957; 17: 237-246
• 2 Mancini G, Carbonara AO, Heremans JF. Immunological quantitation of antigens by a single radial immunodiffusion. Immunochemistry 1965; 2: 235-254
• 3 Abildgaard U, Lie M, Odegard OR. Antithrombin (heparin cofactor) assay with “new” chromogenic substrates S-2238 and Chromozym TH. Thromb Res 1977; 2: 549-553
• 4 Thomson JM. Blood coagulation and haemostasis: A practical guide 1. Churchill, London 1970
• 5 Poller L, Thomson JM. The partial thromboplastin (cephalin) time test. J Clin Pathol 1972; 25: 1038-1044
• 6 Poller L, Thomson JM, Sear CH J, Thomas W. A congenital defect of factor VII in beagle dogs. J Clin Pathol 1971; 24: 626-634
• 7 Aurell L, Simonsson R, Arielly S, Karlsson G, Friberger P, Claeson G. Chromogenic peptide substrates for factor Xa. Haemostasis 1978; 7: 92-94
• 8 Bergstrom K, Egberg N. Determination of vitamin K-sensitive coagulation factors in plasma. Studies on three methods using synthetic chromogenic substrates. Thromb Res 1978; 72: 531-547
• 9 Nilsson IM, Hedner U, Pandolfi M. The measurement of fibrinolytic activities. In Fibrinolysis and antifibrinolytics Markwardt F. (Ed) pp 107-134 Springer-Verlag; Berlin: 1978
• 10 Haverkate F, Timan G. Preparation of highly purified bovine fibrin plates. In Progress in chemical fibrinolysis and thrombolysis methodology Davidson JF, Samama MM, Desnoyers PC. (eds) Vol. 2 73-77 Raven Press; New York: 1976
• 11 Kluft C, Brakman P, Veldhuyzen-Stolk EC. Screening of fibrinolytic activity in plasma euglobulin fractions on the fibrin plate. In Progress in chemical fibrinolysis and thrombolysis Davidson JF, Samama MM, Desnoyers PC. (Eds) Vol. 2 57-65 Raven Press; New York: 1976
• 12 Odegard OR, Lie M, Abildgaard U. Antifactor Xa activity measured with amidolytic methods. Haemostasis 1976; 5: 265-275
• 13 Soria J, Soria C, Samama M. Biologie Prospective III. Colloque de Point-á-Moussin. L’Expansion Scientifique Frangaise 1975
• 14 Teger-Nilsson AC, Friberger P, Gyzander E. Determination of a new rapid plasmin inhibitor in human blood by means of a plasmin specific tripeptide substrate. Scand J Clin Lab Invest 1977; 37: 403-409
• 15 Edy J, de Cock F, Collen D. Inhibition of plasmin by normal and antiplasmin depleted plasma. Thromb Res 1976; 8: 513-518
• 16 Latallo ZS, Teisseyre E, Lopaciuk S. Assessment of plasma fibrinolytic system with use of chromogenic substrate. Haemostasis 1978; 7: 150-154
• 17 Merskey C, Gordon H, Schrire V, Kaplan VJ, Sougin-Mibashan R, Nossel HL, Moodie A. Blood coagulation and fibrinolysis in relation to coronary artery disease. A comparative study of normal white men, white men with overt coronary heart disease and normal Bantu men. Br Med J 1960; 1: 219-227
• 18 Howell M. Comparison of fibrinolysis and coagulation in Nigerian and European men. J Atherosclerosis Res 1965; 5: 80-89
• 19 Barr RD, Ouna N, Kendall AG. The blood coagulation and fibrinolytic enzyme systems in healthy adult Africans and Europeans -a comparative study. Scott Med J 1973; 18: 93-97
• 20 Lee KT, Kim DN, Keokam Y, Thomas WA. Geographic pathology of athersclerosis and thrombosis. Coagulation and clot-lysis phenomena in Koreans on a low-fat diet. J Atherosclerosis Res 1966; 6: 203-213
• 21 Meade TW, Brozovic M, Chakrabarti R, Haines AP, North WR S, Stirling Y. Ethnic group comparisons of variables associated with ischaemic heart disease. Br Med J 1978; 40: 789-795
• 22 Visudhiphan S, Poolsuppasii S, Piboonnukarintr O, Tumliang S. The relationship between high fibrinolytic activity and daily capsicum ingestion in Thais. Am J Clin Nutrit 1982; 35: 1452-1458
• 23 Szczeklik A, Dischinger P, Kueppers F, Tyroler HA, Hames CG, Cassel JC, Creagan S. Blood fibrinolytic activity, social class and habitual physical activity. II. A study of black and white men in Southern Georgia. J Chron Dis 1980; 33: 291-299
• 24 Gill GV, England A, Marshal C. Low platelet count in Zambians. Trans Soc Trop Med Hyg 1979; 73: 111-113
• 25 Walker AR P. Fibrinolytic activity of whole blood from South African Bantu and white subjects. Am J Clin Nutrit 1961; 9: 461-472
• 26 Shaper AG, Jones KW, Kyobe J, Jones M. Fibrinolysis in relation to body fatness, serum lipids and coronary heart disease in Africa and Asian men in Uganda. J Atherosclerosis Res 1966; 6: 313-327
• 27 Thomson JM. Blood coagulation and haemostasis: A practical guide 2. Churchill Livingstone; Edinburgh: 1980
• 28 Essien EM. Enhanced fibrinolysis in Nigerians - probable contributory factor to low prevalence of atherosclerosis in the Nigerian. African J Med Medical Sciences 1976; 5: 287-290
• 29 Menon IS. Fibrinolytic activity in the blood of 99 healthy young British, African and Asian subjects. Laboratory Practice 1968; 17: 194-195
• 30 Gillman T, Naidoo SS, Hathorn M. Fat, fibrinolysis and atherosclerosis in Africans. Lancet 1957; 2: 696-697
• 31 Grieg HB. Inhibition of fibrinolysis by alimentary lipaemia. Lancet 1956; 2: 16-18
• 32 Ogston D. The physiology of haemostasis, p300. Croom Helm; London - Canberra: 1983
• 33 Green G, Poller L, Thomson JM, Dymock IW. Factor VII as a marker of hepatocellular synthetic function in liver disease. J Clin Path 1976; 29: 971-975
• 34 Poller L. Coagulation abnormalities in liver disease. In Recent Advances in Blood Coagulation Poller L. (Ed.) Churchill Livingstone; Edinburgh: 1977
• 35 Walsh JJ, Bonnar J, Wright FW. Study of pulmonary embolism and deep leg vein thrombosis after major gynaecological surgery. J Obst Gynec Br Cwth 1974; 81: 311-315
• 36 Chunmijarakij T, Poshyachina V. Postoperative thrombosis in Thai women. Lancet 1975; i: 1357-1358